Skip to main content

The Blavatnik Fund for Innovation at Yale

The Blavatnik Fund for Innovation at Yale

Accelerating the translation of early-stage life science research into impactful products. 

Since 2017, Yale has 56 projects totaling $18 million* through the Blavatnik Fund for Innovation.

The Blavatnik Fund for Innovation at Yale is a $25 million fund that supports faculty in the commercialization of applied research and technology in the life sciences. The Fund is made possible by a generous grant from the Blavatnik Family Foundation in support of the commercialization of Yale faculty applied research and technology in the life sciences.The Fund’s integrated approach combines business expertise, intensive guidance, and essential funding to support innovative, Yale investigator-initiated research at all levels. The goal of completed projects are partnerships with industry, through licenses to existing biopharmaceutical companies and startups or major industry-sponsored research agreements.  

Blavatnik By The Numbers

56 Funded Projects

14 Biotech Ventures Launched

$18M Total Awards

$230M Raised by Ventures

50+ CRO Contracts

3 FDA Investigational New Drug (IND) status